GlassScriptPhysician profile
Thomas Federico
NPI 1114035243
$377.87
in general payments reported to CMS, 2019-2025
9 companies · $51.47 in 2025
The $51.47 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $50.06 · 2021: $60.06 · 2022: $52.73 · 2023: $29.64 · 2024: $26.59 · 2025: $51.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $107.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $122.93 | 2019-2025 | Triluron, Hymovis, Hyalgan |
| Pacira Therapeutics, INC. | $70.29 | 2019-2021 | |
| Genentech USA, INC. | $53.50 | 2020-2021 | |
| Depuy Synthes Sales INC. | $29.54 | 2019 | |
| Bioventus LLC | $28.93 | 2019 | |
| Horizon Therapeutics Plc | $23.14 | 2020 | |
| Avanos Medical | $17.79 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.95 | 2023 | Adthyza |
| Kowa Pharmaceuticals America, INC. | $15.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Federico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.